Regina Barzilay

Born: 1970

Country of Birth: Moldova

Nationality: Israeli/American

Ethnicity: White

Ben Gurion University of the Negev BS 1993 & MS 1997; Columbia University PhD Computer Science 2002; Postdoc at Cornell University 2003

Field of Study: Computer Science

Institution/Corporation: MIT; Columbia University; Johnson & Johnson

Degrees & Memberships: Member: National Academy of Engineering (2023)American Academy of Arts & Sciences; National Academy of Medicine (2023)Board of Directors Dewpoint Therapeutics (2020)Scientific Advisory board (SAB) Immunai (2019)SAB Johnson & Johnson Janssen R&D (2018)SAB Allurion (2023)

Awards: 2017 MacArthur Fellowship; 2005 NSF Career Award; 2021 AAAI Squirrel AI Award for Artificial Intelligence for the Benefit of Humanity; 2018 Susan G. Komen Scholar; 2021 AACC Wallace H. Coulter Lectureship Award; 2021 UNESCO/Netexplo Award; 2021 School of Engineering distinguished Professor for AI & Health' 2019 named 1 of the Top 100 AI Leaders in Drug Discovery & Advanced Healthcare; 2019 Xconomy Boston Digital Trailblazer; 2018 Ruth & Joel Spira Award for Excellence in Teaching; 2017 AAAI Fellowship; 2017 ACI Fellowship; 2016 Best Paper Award, EMNLP; 2016 Burgess & Elizabeth Jamieson Award for Excellence in Teaching; 2016 Delta Electronics Professor; 2014 Faculty Research Innovation Fellowship; 2014 Best Student Paper Award, ACL; 2006 Ross Career Development Professor; 2006 Microsoft Faculty Fellowship; 2006 IEEE Intelligent Systems AI 10 to Watch list; 2005 Technology Review 35 Top Innovators; 2004 Best Paper Award, HLT/NAACL

Achievements: at MIT is part of a team that in 2020 discovered thru deep learning models halicin, the 1st new antibiotic compound in 30 yrs, which kills over 35 powerful bacteria including antimicrobial-resistant TB, the superbug C. difficile & 2 of WHO's top 3 most deadly bacteria; working on using AI to detect & predict breast cancer